Department of Gastroenterology, The First Hospital of Tsinghua University, No. 6 Jiuxianqiao, 1st Street, Chaoyang District, Beijing 100016, China.
Postgrad Med J. 2024 Nov 22;100(1190):890-897. doi: 10.1093/postmj/qgae112.
Chronic constipation is a prevalent clinical condition. Its etiology and pathogenesis have not yet been fully understood. In recent years, mounting evidence suggests a close association between chronic constipation and intestinal dysbiosis, including alterations in the colony structure and metabolites, as well as the modulation of bowel movements via the brain-gut-microbiota axis. With the deepening of related research, probiotic-related therapies are expected to become a potential first-line treatment for chronic constipation in the future. In this review, we summarize the current research insights into the intricate relationships between chronic constipation and the gut microbiota and briefly discuss several different approaches for treating chronic constipation. The findings from this review may advance our understanding of the pathological mechanisms underlying chronic constipation and, ultimately, translate them into improvements in patient care.
慢性便秘是一种常见的临床病症。其病因和发病机制尚未完全阐明。近年来,越来越多的证据表明,慢性便秘与肠道菌群失调密切相关,包括菌群结构和代谢物的改变,以及通过脑-肠-微生物群轴调节肠道运动。随着相关研究的深入,益生菌相关治疗有望成为未来慢性便秘的潜在一线治疗方法。本文综述了慢性便秘与肠道菌群之间复杂关系的研究进展,并简要讨论了几种治疗慢性便秘的不同方法。本综述的研究结果可能有助于我们深入了解慢性便秘的病理机制,并最终转化为改善患者的治疗效果。